Historical record - last NADAC effective date: 5/19/2021
Product Information
NAPROXEN DR 375 MG TABLET is a generic product labeled by Cipla USA Inc., priced at $0.3749 per EA under NDC 69097085107. Its NADAC has been published 246 times since Sep 14, 2016.
FDA first approved this application on Sep 19, 2011. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Naproxen market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
375 mg/1
Manufacturer
Cipla USA Inc.NDC
69097085107
Classification
Generic
Dosage Form
TABLET, DELAYED RELEASE
Route
ORAL
Effective Date
5/19/2021
Active Ingredients
NAPROXENApproval Type
Generic (ANDA)
FDA Application
ANDA091432FDA Approved
9/19/2011
TE Code
AB
On Market Since
7/5/2016
Pharmacological Classes
Price Statistics
The NADAC for NAPROXEN DR 375 MG TABLET has been published 246 times since Sep 14, 2016, and over the history we have for it it has risen 169.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3749 per EA |
|---|---|
| All-time high | $0.8898 (May 13, 2020) |
| All-time low | $0.1137 (Nov 21, 2018) |
| Median price | $0.1485 |
| Average price | $0.2004 |
| Largest weekly change | +366.3% (Mar 18, 2020) |
| Weeks tracked | 246 |
| Tracking since | Sep 14, 2016 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+169.0%
Last surveyed May 26, 2021 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 85% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of NAPROXEN DR 375 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for NAPROXEN DR 375 MG TABLET, manufactured by Cipla USA Inc., is $0.3749 per EA (NDC 69097085107), effective May 26, 2021.
How has the price of NAPROXEN DR 375 MG TABLET changed over time?
Over the history we have for it, the NADAC for NAPROXEN DR 375 MG TABLET has risen 169.0%. It has been tracked across 246 weekly CMS publications since Sep 14, 2016.
What are the highest and lowest recorded NADAC prices for NAPROXEN DR 375 MG TABLET?
Since Sep 14, 2016, the NADAC for NAPROXEN DR 375 MG TABLET has ranged from a low of $0.1137 (Nov 21, 2018) to a high of $0.8898 (May 13, 2020), with a median of $0.1485 per EA.
Are there cheaper alternatives to NAPROXEN DR 375 MG TABLET?
Yes. 9 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, NAPROXEN 375 MG TABLET, is $0.0561 per EA — about 85% below NAPROXEN DR 375 MG TABLET.
Who manufactures NAPROXEN DR 375 MG TABLET?
NAPROXEN DR 375 MG TABLET (NDC 69097085107) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.